Lipitor halves stroke risk in diabetes patients

June 8, 2004

New Lipitor data suggests the drug cut the risk of stroke by half in diabetes patients, the compelling evidence potentially …

Shire relocates R&D headquarters to US

June 3, 2004

Shire Pharmaceuticals has relocated its research and development headquarters to the US as the company looks to increase its penetration …

Oxford BioMedica one step closer to Holy Grail of nerve damage

June 3, 2004

The promise of a gene-based technology which might one day cure spinal injuries and paralysis has moved one step closer …

PCT claims bullying over private contract

June 3, 2004

An NHS trust chairman has accused the government of bullying it into awarding a contract to a private firm, resulting …

Unmet needs in arthritis

June 3, 2004

Although there is no cure for rheumatoid arthritis (RA), a wide range of drugs are involved in its treatment. Similar …

CROs: flexible or overstretched?

June 3, 2004

If only I had known then what I know now about the labyrinthine world of Contract Research Organisations (CROs). This …

Counterfeit medicines on the rise

June 1, 2004

The World Health Organisation (WHO) estimates that up to 10% of medicines worldwide may be counterfeit, costing the pharmaceutical industry …

Making the most of your talent

May 27, 2004

The vast majority of pharma executives would argue that having a large number of products in any company's portfolio should …

Roche prescribing data to support NICE uptake

May 27, 2004

Roche is to provide NICE with regular updates on patient access to its treatments to help increase the uptake of …

NICE strikes deal with industry on data confidentiality

May 26, 2004

The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …

The downside to downsizing

May 24, 2004

It used to be that the pharmaceutical industry was virtually recession-proof. When times were bad, the unemployed had more time …

Sanofi takes charge of arranged marriage

May 24, 2004

Sanofi-Synthelabo chief executive Jean-Francois Dehecq is preparing his company to merge with larger Franco-German neighbours Aventis to create the world's …

Velcade launched in UK

May 24, 2004

Velcade, the first in a new class of cancer drugs has been launched in the UK as a third line …

The Gateway to Local Adoption Series

Latest content